Tirzepatide activates GLP-1 and GIP receptors, which are involved in metabolic regulation. GLP-1 signalling plays an important role in appetite control by influencing areas of the brain responsible for hunger and food intake. GIP signalling also contributes to metabolic functions and may work alongside GLP-1 activity.
These combined mechanisms can influence how frequently a person experiences hunger and how much food they consume.
GLP-1 receptor activation: Helps regulate appetite-related signals and contributes to feelings of fullness.
GIP receptor activation: Supports metabolic regulation and works alongside GLP-1 pathways.
Reduced hunger signals: May decrease the frequency or intensity of hunger sensations.
Increased satiety: Can help individuals feel satisfied after eating.
Food intake regulation: May contribute to reduced calorie consumption through changes in appetite.
Tirzepatide also influences communication between the gastrointestinal system and the central nervous system. These signals contribute to the body's understanding of hunger and fullness, which can affect eating behaviour over time.
Appetite regulation involves several interconnected systems, including digestive hormones, stomach activity, and brain pathways. Tirzepatide influences these systems through its dual receptor activity. One important effect is delayed gastric emptying, particularly during the initial stages of treatment. This means food may remain in the stomach longer, contributing to prolonged feelings of fullness after meals.
The medication also affects brain regions involved in appetite and food intake. These areas help process hormonal signals related to energy balance and eating behaviour.
Delayed gastric emptying: Slows the movement of food from the stomach into the small intestine, particularly early in treatment.
Brain signalling: Influences pathways involved in hunger, satiety, and food consumption.
Meal satisfaction: May contribute to feeling full after consuming smaller portions.
Eating patterns: Changes in appetite may influence meal frequency and portion sizes.
Hormonal communication: Supports interactions between digestive hormones and metabolic control systems.
The combined effects of gastrointestinal activity and hormonal signalling explain how tirzepatide influences appetite regulation. Individual responses can vary, and gastrointestinal side effects such as nausea, vomiting, diarrhoea, constipation, and abdominal discomfort may occur during treatment.